Editorial
When the doctor is sick too
Syria: a health crisis too great to ignore
Substance use in young people
Comment
Dupilumab: a potential new treatment for severe asthma
Treatment of chronic immune thrombocytopenia in children with romiplostim
Novel approach to in-vivo oesophageal regeneration
The French experience of the threat posed by Zika virus
Moving pictures: Highlights 2016 open for submissions
World Report
US law agencies target “high prescribers” of pain relief
Drug development partnerships look set to grow
Perspectives
Perspectives on mortality
Bad reputation
Julie Makani: at the cutting edge of sickle-cell disease
Correspondence
Is Zika a substantial risk for visitors to the Rio de Janeiro Olympic Games?
The Hajj health requirements: changing a mindset
Happiness, health, and mortality
Post-sanctions era in Iran: opportunity for science and publication
Articles
Dupilumab efficacy and safety in adults with uncontrolled persistent asthma despite use of medium-to-high-dose inhaled corticosteroids plus a long-acting β2 agonist: a randomised double-blind placebo-controlled pivotal phase 2b dose-ranging trial
Romiplostim in children with immune thrombocytopenia: a phase 3, randomised, double-blind, placebo-controlled study
In-vivo oesophageal regeneration in a human being by use of a non-biological scaffold and extracellular matrix
Caesarean section surgical techniques: 3 year follow-up of the CORONIS fractional, factorial, unmasked, randomised controlled trial